Reserpine use in specific populations

Revision as of 15:37, 7 March 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Reserpine}} {{CMG}}; {{AE}} {{AK}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RESERPINE TABLET [EON LABS, INC.] | url = http://d...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Reserpine
Reserpine® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Reserpine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]


[1]


References

  1. ↑ "RESERPINE TABLET [EON LABS, INC.]". Retrieved 7 March 2014.
Retrieved from "https://www.wikidoc.org/index.php?title=Reserpine_use_in_specific_populations&oldid=952211"